Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
35.02
-0.05 (-0.14%)
Jan 26, 2026, 11:21 AM EST - Market open

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of 131.62M CNY in the quarter ending September 30, 2025, with 2.31% growth. This brings the company's revenue in the last twelve months to 539.28M, up 5.56% year-over-year. In the year 2024, Burning Rock Biotech had annual revenue of 515.82M, down -4.02%.

Revenue (ttm)
539.28M CNY
Revenue Growth
+5.56%
P/S Ratio
4.93
Revenue / Employee
800,111 CNY
Employees
674
Market Cap
377.05M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024515.82M-21.61M-4.02%
Dec 31, 2023537.44M-25.80M-4.58%
Dec 31, 2022563.24M55.38M10.90%
Dec 31, 2021507.86M77.96M18.13%
Dec 31, 2020429.90M48.23M12.64%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics825.30M
OPKO Health642.07M
CareDx358.00M
Castle Biosciences343.53M
Fulgent Genetics315.55M
FONAR105.43M
MDxHealth103.07M
Prenetics Global77.08M
Revenue Rankings